Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$42.05 - $47.77 $11,185 - $12,706
266 Added 1.9%
14,239 $620,000
Q1 2022

May 12, 2022

SELL
$40.23 - $47.74 $51,896 - $61,584
-1,290 Reduced 8.45%
13,973 $608,000
Q4 2021

Jan 27, 2022

BUY
$38.88 - $45.31 $40,046 - $46,669
1,030 Added 7.24%
15,263 $674,000
Q3 2021

Nov 12, 2021

SELL
$38.79 - $43.16 $9,969 - $11,092
-257 Reduced 1.77%
14,233 $544,000
Q2 2021

Aug 06, 2021

BUY
$36.52 - $41.46 $72,419 - $82,215
1,983 Added 15.86%
14,490 $577,000
Q1 2021

May 13, 2021

SELL
$34.27 - $40.01 $31,871 - $37,209
-930 Reduced 6.92%
12,507 $455,000
Q4 2020

Feb 09, 2021

BUY
$34.07 - $39.94 $3,168 - $3,714
93 Added 0.7%
13,437 $495,000
Q2 2020

Aug 05, 2020

BUY
$37.87 - $43.58 $10,262 - $11,810
271 Added 2.07%
13,344 $545,000
Q1 2020

Apr 30, 2020

SELL
$32.47 - $48.83 $57,406 - $86,331
-1,768 Reduced 11.91%
13,073 $495,000
Q4 2019

Feb 04, 2020

SELL
$42.0 - $48.25 $51,450 - $59,106
-1,225 Reduced 7.62%
14,841 $697,000
Q3 2019

Nov 07, 2019

BUY
$40.46 - $43.52 $4,855 - $5,222
120 Added 0.75%
16,066 $684,000
Q2 2019

Jul 19, 2019

SELL
$39.4 - $42.7 $35,538 - $38,515
-902 Reduced 5.35%
15,946 $638,000
Q1 2019

May 13, 2019

SELL
$38.57 - $42.69 $100,783 - $111,548
-2,613 Reduced 13.43%
16,848 $705,000
Q4 2018

Feb 12, 2019

BUY
$37.8 - $42.69 $15,686 - $17,716
415 Added 2.18%
19,461 $743,000
Q3 2018

Nov 06, 2018

BUY
$39.75 - $42.69 $21,465 - $23,052
540 Added 2.92%
19,046 $765,000
Q2 2018

Jul 25, 2018

BUY
$39.61 - $42.76 $85,319 - $92,105
2,154 Added 13.17%
18,506 $746,000
Q1 2018

May 10, 2018

SELL
$36.18 - $40.15 $12,626 - $14,012
-349 Reduced 2.09%
16,352 $640,000
Q4 2017

Jan 30, 2018

SELL
$35.34 - $41.9 $216,033 - $256,134
-6,113 Reduced 26.79%
16,701 $592,000
Q3 2017

Nov 03, 2017

BUY
$39.44 - $41.55 $899,784 - $947,921
22,814
22,814 $926,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $67.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.